Safety of 2 Recombinant Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Vaccines in Neonates Born to HIV-1-Infected WomenColeen K. Cunningham, William Borkowsky, D. W. Wara et al.|Clinical Infectious Diseases|2001Cited by 75
Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assaysAdriana Weinberg, Nancy B. Tustin, Lin Song et al.|Journal of Immunological Methods|2010Cited by 68
Human Immunodeficiency Virus Type 1 (HIV‐1) gp120–Specific Antibodies in Neonates Receiving an HIV‐1 Recombinant gp120 VaccineElizabeth J. McFarland, Robert A. Livingston, William Borkowsky et al.|The Journal of Infectious Diseases|2001Cited by 62
Lymphoproliferative Responses to Recombinant HIV‐1 Envelope Antigens in Neonates and Infants Receiving gp120 VaccinesWilliam Borkowsky, Eleanor Jiménez, Diane W. Wara et al.|The Journal of Infectious Diseases|2000Cited by 53
Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapyThomas C. Greenough, Katherine Luzuriaga, Coleen K. Cunningham et al.|Vaccine|2008Cited by 43